InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+9.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Rhode Peter, Executive. Officer active across 1 company, notably HCW Biologics Inc.. Aggregated, 6 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €170k. Activity tracked since 22 July 2021. The latest transaction was filed on 11 December 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
14,000 shares@ US$0.141.0% of flowCommon StockSEC:0001209191-23-058082:0
15,000 shares@ US$0.141.1% of flowCommon StockSEC:0001209191-23-056086:0
1,714 shares@ US$0.210.0038% mcap0.2% of flowCommon StockSEC:0001209191-22-003785:0
1,714 shares@ US$0.210.2% of flowCommon StockSEC:0001209191-22-003785
12,500 shares@ US$8.0048.7% of flowCommon StockSEC:0001209191-21-048082
Ideal exit: 18 Apr 2022 (T+270)
12,500 shares@ US$8.001.03% mcap49.8% of flowCommon StockSEC:0001209191-21-048082:0
Ideal exit: 18 Apr 2022 (T+270)
6 of 6 declarations
About Rhode Peter
Peter Rhode is an Executive at HCW Biologics Inc. While his specific role is not detailed, he contributes to the leadership and management of the company's operations. Peter is involved in making strategic decisions that influence the organization's performance and growth. His expertise is essential for the development of the company's initiatives.
